Imago BioSciences, Inc. Stock Price

NasdaqGS:IMGO Community·US$1.2b Market Cap

0 Narratives written by author
0 Comments on narratives written by author
0 Fair Values set on narratives written by author

Create a narrative

IMGO Share Price Performance

US$0

0.00 (0.00%)

US$0

0.00 (0.00%)

US$0

Sun, 5 Apr 26

Share Pricen/a

IMGO Community Narratives

There are no narratives available yet.

Create a narrative

There are no community narratives available.

Trending Discussion

Snowflake Analysis

Flawless balance sheet with weak fundamentals.

3 Risks

0 Rewards

View Full Analysis

Imago BioSciences, Inc. Key Details

Last Reported Earnings

Sep 30, 2022

Next Reporting Earnings

n/a

: -1.82
: 0%
: 0%
: 0%

View Full Analysis

About IMGO

Founded: 2012
Employees: 41
CEO: Hugh Rienhoff
WebsiteView website: www.imagobio.com

Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.